Inhibition of the Akt1-mTORC1 Axis Alters Venous Remodeling to Improve Arteriovenous Fistula Patency
Open Access
- 30 July 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 9 (1), 1-16
- https://doi.org/10.1038/s41598-019-47542-5
Abstract
Arteriovenous fistulae (AVF) are the most common access created for hemodialysis, but up to 60% do not sustain dialysis within a year, suggesting a need to improve AVF maturation and patency. In a mouse AVF model, Akt1 regulates fistula wall thickness and diameter. We hypothesized that inhibition of the Akt1-mTORC1 axis alters venous remodeling to improve AVF patency. Daily intraperitoneal injections of rapamycin reduced AVF wall thickness with no change in diameter. Rapamycin decreased smooth muscle cell (SMC) and macrophage proliferation; rapamycin also reduced both M1 and M2 type macrophages. AVF in mice treated with rapamycin had reduced Akt1 and mTORC1 but not mTORC2 phosphorylation. Depletion of macrophages with clodronate-containing liposomes was also associated with reduced AVF wall thickness and both M1- and M2-type macrophages; however, AVF patency was reduced. Rapamycin was associated with improved long-term patency, enhanced early AVF remodeling and sustained reduction of SMC proliferation. These results suggest that rapamycin improves AVF patency by reducing early inflammation and wall thickening while attenuating the Akt1-mTORC1 signaling pathway in SMC and macrophages. Macrophages are associated with AVF wall thickening and M2-type macrophages may play a mechanistic role in AVF maturation. Rapamycin is a potential translational strategy to improve AVF patency.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01-HL128406)
This publication has 44 references indexed in Scilit:
- The Nogo-B-PirB Axis Controls Macrophage-Mediated Vascular RemodelingPLOS ONE, 2013
- Rapamycin unbalances the polarization of human macrophages to M1Immunology, 2013
- Inflammation, Oxidation and Venous Neointimal Hyperplasia Precede Vascular Injury from AVF Creation in CKD PatientsThe Journal of Vascular Access, 2011
- Endothelial Function Predicts Positive Arterial-Venous Fistula Remodeling in Subjects with Stage IV and V Chronic Kidney DiseaseThe Journal of Vascular Access, 2010
- The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and MetabolismImmunity, 2010
- Immunoregulatory functions of mTOR inhibitionNature Reviews Immunology, 2009
- Molecular mechanisms of mTOR-mediated translational controlNature Reviews Molecular Cell Biology, 2009
- Rapamycin and mTOR kinase inhibitorsJournal of Chemical Biology, 2008
- Early Adaptive Responses of the Vascular Wall during Venous Arterialization in MiceThe American Journal of Pathology, 2004
- Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidizationJCI Insight, 2000